Cargando…

Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure

BACKGROUND: Previous studies suggested increased mortality in patients with hepatorenal syndrome type 1 (HRS1) and advanced acute‐on‐chronic liver failure (ACLF). AIM: To assess mortality and respiratory failure (RF) in patients with HRS1 and ACLF treated with terlipressin. METHODS: In the CONFIRM s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Florence, Pappas, Stephen Chris, Reddy, K. Rajender, Vargas, Hugo, Curry, Michael P., Sanyal, Arun, Jamil, Khurram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Terlipressin in Hepatorenal Syndrome Type 1
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804971/ https://www.ncbi.nlm.nih.gov/pubmed/35995728 http://dx.doi.org/10.1111/apt.17195

Ejemplares similares

Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome
por: Moore, Kevin, et al.
Publicado: (2020)

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT‐0401 and REVERSE randomised clinical studies
por: Sanyal, A. J., et al.
Publicado: (2017)

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
por: Curry, Michael P., et al.
Publicado: (2023)

Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome
por: Wong, Florence, et al.
Publicado: (2019)

Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
por: Karvellas, Constantine J., et al.
Publicado: (2023)

Hepatorenal syndrome:Response to terlipressin and albumin and its determinants
por: Sarwar, Shahid, et al.
Publicado: (2016)

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT
por: Belcher, Justin M.
Publicado: (2023)

In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V(1) and V(2)
por: Jamil, Khurram, et al.
Publicado: (2017)

An investigation of reconstituted terlipressin infusion stability for use in hepatorenal syndrome
por: Bui, Thi Ngoc Nhieu, et al.
Publicado: (2020)

Global Public Health Burden of Heart Failure: An Updated Review
por: Shahim, Bahira, et al.
Publicado: (2023)

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis
por: Wang, Haiqing, et al.
Publicado: (2018)

Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction
por: Kapelios, Chris J, et al.
Publicado: (2023)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
por: Kim, Hae Rim, et al.
Publicado: (2013)

Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome
por: Chiang, Chi-Wen, et al.
Publicado: (2019)

Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
por: Mohamed, Mohamed M G, et al.
Publicado: (2021)

Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
por: Ayyad, Ahlam, et al.
Publicado: (2023)

Congestion and Diuretic Resistance in Acute or Worsening Heart Failure
por: Kristjánsdóttir, Ingibjörg, et al.
Publicado: (2020)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
por: Ţica, Otilia, et al.
Publicado: (2022)

Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis
por: Hiremath, Sharanabasayyaswamy B., et al.
Publicado: (2013)

Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
por: Nassar Junior, Antonio Paulo, et al.
Publicado: (2014)

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?
por: Altun, Reskan, et al.
Publicado: (2015)

The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
por: Flamm, Steven L., et al.
Publicado: (2021)

Co-occurrence of Myocardial Sarcoidosis and Left Ventricular Non-compaction in a Patient with Advanced Heart Failure
por: Kumar, Anupam A, et al.
Publicado: (2022)

Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function
por: Huang, Xingyue, et al.
Publicado: (2023)

Severe Scratching in Spinocerebellar Ataxia 17: Another Case
por: Pauly, Martje G., et al.
Publicado: (2020)

Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients
por: Gupta, Harsh V., et al.
Publicado: (2020)

Late-Onset Tay-Sachs Disease - expanding the clinical phenotype
por: Lefter, Stela, et al.
Publicado: (2023)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

Terlipressin-Induced Skin Necrosis While Managing Hepatorenal Syndrome: A Rare Case Report From North India
por: Sudan, Sourav, et al.
Publicado: (2023)

A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug
por: Thangaraj, Santhosh Raja, et al.
Publicado: (2023)

The Hepatorenal Syndrome Patient Pathway: Retrospective Analysis of Electronic Health Records
por: Jamil, Khurram, et al.
Publicado: (2022)

Personal Education Programme in Sweden
por: Muoi, Nguyen Thi
Publicado: (1999)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Flow Cytometry”: Guest Editor for the “Flow cytometry” issue: Katherina Psarra
Publicado: (2019)

Call for Manuscript Submissions for a Thematic eJIFCC Issue on “Improving the Preanalytical Phase in Laboratory Medicine”: Guest Editor for the “Pre-analytical phase” issue: Gabriel Lima-Oliveira
Publicado: (2019)

Request for Nominations for Members for the Committee on Laboratory Management of the Education and Management Division of IFCC
por: Wilkinson, I.
Publicado: (2003)

Past Lives
por: Williams, David L.
Publicado: (2003)

Development of Reference Methods and Reference Materials by the IFCC: An Overview
por: FOREST, JEAN-CLAUDE, et al.
Publicado: (2001)

IFCC Professional Scientific Exchange Programme (PSEP) Report: Plasma Protein Separation Techniques: Ishmael Kasvosve, Zimbabwe: - Report on Scientific Visit
por: Kasvosve, Ishmael
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_u6hsbairgc9k439m69vr2vfj3g